A California jury on Monday ordered Johnson & Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene.
- AstraZeneca ups investment in messenger RNA drugs with Ethris deal
- Parents still failing to put babies to sleep on their backs
- Smokers hospitalized for heart attacks often don't get cessation drugs
- Belgian biscuit maker recalls products amid contaminated eggs scare
- U.S. study revives argument over mammogram screening
LONDON Britain's Creo Medical Group said its device to remove cancerous lesions in the bowel during an endoscopy had received U.S. approval much quicker than it planned, shaking up a timetable that had been focused on a European launch.
ASL Strategic Value Fund has sought the replacement of hospital operator Community Health Systems Inc's chief executive, Wayne Smith.
LONDON Novartis is taking aim at drug-resistant malaria – a growing global problem – by launching clinical trials of the first new antimalarial medicine for many years in nine countries across Africa and Asia.
LONDON Pharmaceutical company Shire said its chief financial officer Jeff Poulton will stand down at the end of the year to join Indigo Ag, a Boston-based start-up that seeks to improve agricultural productivity.